Heart Rate Variability Biofeedback for Substance Use Disorder: A Randomized Clinical Trial.

ABSTRACT:

Importance

Preliminary studies suggest heart rate variability biofeedback (HRVB) may reduce craving and negative affect in individuals with substance use disorder (SUD), but few studies have evaluated whether this translates into improved substance use outcomes, and no prior studies have examined second-generation wearable HRVB technology in this context.

Objective

To evaluate the effects of second-generation HRVB on negative affect, positive affect, craving, and alcohol and other drug (AOD) use in adults with SUD.

Design, setting, and participants

This phase 2 randomized clinical trial included 8 weeks of outpatient treatment. Recruitment was conducted virtually across the US from February 2023 to June 2024. Treatment-seeking adults with SUD were randomized to receiv

SUBMITTER: Eddie D 

PROVIDER: S-EPMC12489796 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature